Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

Latest Pivotal bioVenture Partners Investment Advisor LLC Stock Portfolio

Pivotal bioVenture Partners Investment Advisor LLC Performance:
2025 Q2: 6.41%YTD: -20.47%2024: 22.7%
Performance for 2025 Q2 is 6.41%, and YTD is -20.47%, and 2024 is 22.7%.

About Pivotal bioVenture Partners Investment Advisor LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Pivotal bioVenture Partners Investment Advisor LLC reported an equity portfolio of $161.3 Millions as of 30 Jun, 2025.

The top stock holdings of Pivotal bioVenture Partners Investment Advisor LLC are , PCVX, ARQT. The fund has invested 27.7% of it's portfolio in OCULIS HOLDING AG and 26.3% of portfolio in VAXCYTE INC.

The fund managers got completely rid off BOLT BIOTHERAPEUTICS INC (BOLT) stocks. Pivotal bioVenture Partners Investment Advisor LLC opened new stock positions in TREVI THERAPEUTICS INC (TRVI) and BOLT BIOTHERAPEUTICS INC (BOLT). The fund showed a lot of confidence in some stocks as they added substantially to VAXCYTE INC (PCVX) and ZENAS BIOPHARMA INC.

Pivotal bioVenture Partners Investment Advisor LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Pivotal bioVenture Partners Investment Advisor LLC made a return of 6.41% in the last quarter. In trailing 12 months, it's portfolio return was -13.87%.
20212022202320242025−40−2002040Performance (%)PerformanceS&P 500

New Buys

Ticker$ Bought
trevi therapeutics inc6,269,220
bolt biotherapeutics inc545,686
New stocks bought by Pivotal bioVenture Partners Investment Advisor LLC

Additions

Ticker% Inc.
vaxcyte inc83.63
zenas biopharma inc5.76
Additions to existing portfolio by Pivotal bioVenture Partners Investment Advisor LLC

Reductions

None of the existing positions were reduced by Pivotal bioVenture Partners Investment Advisor LLC

Sold off

Ticker$ Sold
bolt biotherapeutics inc-756,587
Pivotal bioVenture Partners Investment Advisor LLC got rid off the above stocks

Sector Distribution

Pivotal bioVenture Partners Investment Advisor LLC has about 66% of it's holdings in Healthcare sector.

66%34%
Sector%
Healthcare66
Others34

Market Cap. Distribution

Pivotal bioVenture Partners Investment Advisor LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

34%32%26%
Category%
UNALLOCATED34
SMALL-CAP31.4
MID-CAP26.3
MICRO-CAP7.9

Stocks belong to which Index?

About 64.9% of the stocks held by Pivotal bioVenture Partners Investment Advisor LLC either belong to S&P 500 or RUSSELL 2000 index.

65%35%
Index%
RUSSELL 200064.9
Others35.1
Top 5 Winners (%)%
VIGL
vigil neuroscience inc
346.6 %
INZY
inozyme pharma inc
339.6 %
IOBT
io biotech inc
27.5 %
Top 5 Winners ($)$
INZY
inozyme pharma inc
13.9 M
VIGL
vigil neuroscience inc
3.5 M
IOBT
io biotech inc
0.3 M
Top 5 Losers (%)%
RLYB
rallybio corp
-48.0 %
ARQT
arcutis biotherapeutics inc
-10.4 %
PCVX
vaxcyte inc
-8.1 %
RXRX
recursion pharmaceuticals in
-4.3 %
Top 5 Losers ($)$
PCVX
vaxcyte inc
-3.7 M
ARQT
arcutis biotherapeutics inc
-3.4 M
RLYB
rallybio corp
-0.8 M
RXRX
recursion pharmaceuticals in
-0.1 M

Pivotal bioVenture Partners Investment Advisor LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

PCVXARQTINZYTRVIVIGLRXRXIO..R..BOLT

Current Stock Holdings of Pivotal bioVenture Partners Investment Advisor LLC

Pivotal bioVenture Partners Investment Advisor LLC has 12 stocks in it's portfolio. PCVX proved to be the most loss making stock for the portfolio. INZY was the most profitable stock for Pivotal bioVenture Partners Investment Advisor LLC last quarter.

Last Reported on: 13 Aug, 2025
TickerNamesorted descending% PortfolioShares Held$ ValueType% ChangeOptions